Drug LitigationFDA Warns about Transvaginal Mesh Devices

January 4, 2013

The Food and Drug Administration (FDA), the U.S. government’s health and drug safety watchdog, has communicated recently that health care professionals should be aware that transvaginal mesh devices have caused more than 1,000 reported adverse events.

 

Health care professionals aren’t the only ones who should be aware of complications such as device erosion, pain, infection, and complete ineffectiveness. Patients suffering from pelvic organ prolapse (POP) and stress urinary incontinence (SUI) should be mindful of the risks, too. While this information is prospectively important for the medical community and potential patients, it’s retrospectively important for injured patients and the dedicated attorneys who may represent their interests.

 

Has a transvaginal mesh erosion or other complication impacted your life? The attorneys at the Dallas law firm of Nachawati Law Group know how to defend your legal interests and articulate your desire for justice. Find out how we may be able to help you.  

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy